Joinn Laboratories directors, executives complete share reductions

Beijing Joinn Laboratories (China) Co., Ltd. announced the results of A-share holding reductions by its directors, supervisors, and senior management. The reduction plans, disclosed on September 9, 2025, concluded on November 28, 2025.

Director and deputy general manager Sun Yunxia reduced her holdings by 319,940 shares through centralized bidding, totaling CNY 10,514,139.80, with an average price range of CNY 27.99 to CNY 36.55 per share. Director, general manager, and board secretary Gao Dapeng reduced his holdings by 25,500 shares for CNY 831,585.00, while director and deputy general manager Gu Jingliang sold 66,509 shares, amounting to CNY 2,363,064.77.

Supervisor Li Ye reduced her holdings by 2,000 shares for CNY 71,000.00, and chief financial officer Yu Aishui completed his planned reduction, selling 8,500 shares for CNY 237,065.00. The total combined reduction across these individuals was 848,300 shares, representing 0.1132% of the company's total share capital. The company confirmed that the actual reductions met or exceeded the minimum planned reduction quantities and complied with relevant regulations.